These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22155856)

  • 1. Preoperative radiotherapy combined with S-1 for advanced lower rectal cancer: phase I trial.
    Morimoto S; Shimada M; Kurita N; Sato H; Iwata T; Nishioka M; Yoshikawa K; Miyatani T; Kashihara H; Takasu C; Ikushima H
    Hepatogastroenterology; 2012; 59(117):1428-32. PubMed ID: 22155856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I/II study of preoperative concurrent chemoradiotherapy with S-1 for locally advanced, resectable rectal adenocarcinoma.
    Sadahiro S; Suzuki T; Tanaka A; Okada K; Kamijo A; Murayama C; Akiba T; Nakayama Y
    Oncology; 2011; 81(5-6):306-11. PubMed ID: 22156392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer.
    Sato H; Shimada M; Kurita N; Iwata T; Yoshikawa K; Higashigima J; Chikakio M; Kashihara H; Takasu C; Matsumoto N; Eto S
    Int J Clin Oncol; 2015 Jun; 20(3):543-8. PubMed ID: 25080061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer.
    Ikeda M; Ioka T; Ito Y; Yonemoto N; Nagase M; Yamao K; Miyakawa H; Ishii H; Furuse J; Sato K; Sato T; Okusaka T
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):163-9. PubMed ID: 22677367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I study of concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma.
    Tsuji H; Kiba T; Nagata M; Inoue T; Yukawa H; Yamashita T; Shimode Y; Murata H; Nagata K; Tomoda K
    Oncology; 2006; 71(5-6):369-73. PubMed ID: 17851262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer.
    Sudo K; Yamaguchi T; Ishihara T; Nakamura K; Shirai Y; Nakagawa A; Kawakami H; Uno T; Ito H; Saisho H
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):219-24. PubMed ID: 17189072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of preoperative chemoradiation therapy with S-1 for low rectal cancer.
    Funahashi K; Koike J; Shiokawa H; Ushigome M; Shimada H; Kaneko H; Terahara A
    Hepatogastroenterology; 2014; 61(129):99-104. PubMed ID: 24895802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of neoadjuvant preoperative chemotherapy with S-1 and irinotecan plus radiation in patients with locally advanced rectal cancer.
    Sato T; Kokuba Y; Koizumi W; Hayakawa K; Okayasu I; Watanabe M
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1442-7. PubMed ID: 17855009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I dose escalation study of oxaliplatin plus oral S-1 and pelvic radiation in patients with locally advanced rectal cancer (SHOGUN trial).
    Ishihara S; Matsusaka S; Kondo K; Horie H; Uehara K; Oguchi M; Murofushi K; Ueno M; Mizunuma N; Shinbo T; Kato D; Okuda J; Hashiguchi Y; Nakazawa M; Sunami E; Kawai K; Yamashita H; Okada T; Ishikawa Y; Nakajima T; Watanabe T
    Radiat Oncol; 2015 Jan; 10():24. PubMed ID: 25612635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer.
    Shinchi H; Maemura K; Mataki Y; Kurahara H; Sakoda M; Ueno S; Hiraki Y; Nakajo M; Natsugoe S; Takao S
    J Hepatobiliary Pancreat Sci; 2012 Mar; 19(2):152-8. PubMed ID: 21647560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter phase I study of preoperative chemoradiotherapy with S-1 and irinotecan for locally advanced lower rectal cancer (SAMRAI-1).
    Sato T; Hayakawa K; Tomita N; Noda M; Kamikonya N; Watanabe T; Kato D; Sakai Y; Hiraoka M; Shimada M; Ikushima H; Baba H; Oya N; Oya M; Nemoto-Murofushi K; Takeuchi M; Watanabe M
    Radiother Oncol; 2016 Aug; 120(2):222-7. PubMed ID: 27317556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer.
    Zhu AX; Clark JW; Ryan DP; Meyerhardt JA; Enzinger PC; Earle CC; Fuchs CS; Regan E; Anbe H; Houghton M; Zhang J; Urrea P; Kulke MH
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):285-93. PubMed ID: 16786333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
    Vestermark LW; Jensen HA; Pfeiffer P
    Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer].
    Jin J; Li YX; Liu YP; Wang WH; Li T; Li N; Song YW
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):393-6. PubMed ID: 17045010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preoperative chemoradiotherapy with S-1 for advanced low rectal cancer].
    Kitani K; Okajima K; Sato K; Isono S; Kimura H; Ikeda M; Inoue K; Iwama M; Tsujie M; Nakayama T; Fujiwara Y; Murata M; Yukawa M; Ota Y; Inoue M
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2122-4. PubMed ID: 22202303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
    Kaira K; Sunaga N; Yanagitani N; Kawata T; Utsugi M; Shimizu K; Ebara T; Kawamura H; Nonaka T; Ishikawa H; Sakurai H; Suga T; Hara K; Hisada T; Ishizuka T; Nakano T; Mori M
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):109-14. PubMed ID: 18929446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method.
    Morita S; Nakata B; Tsuji A; Mitachi Y; Shirasaka T; Saji S; Ohashi Y; Sakamoto J; Hirakawa K
    Jpn J Clin Oncol; 2007 Dec; 37(12):924-9. PubMed ID: 18211983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of modified short-course radiotherapy combined with a chemoradiosensitizer for T3 rectal cancer.
    Beppu N; Matsubara N; Kakuno A; Doi H; Kamikonya N; Yamanaka N; Yanagi H; Tomita N
    Dis Colon Rectum; 2015 May; 58(5):479-87. PubMed ID: 25850834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer.
    Hokita S; Aikou T; Miyazono F; Ishigami S; Aridome K; Maenohara S; Saihara T; Suenaga K; Nomura H; Maeda S; Takatori H; Arima H; Uchikado Y; Natsugoe S; Takao S
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):736-40. PubMed ID: 16163539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.